January 28, 2025 TRxA Funding Opportunities 2025 On January 28, C-Path’s Translational Therapeutics Accelerator (TRxA)...
January 28, 2025-January 29, 2025 2025 CRDSA Summit Recordings Available Featuring a keynote address by C-Path CEO Klaus Romero, the first day of...
January 23, 2025 C-Path Announces Jennifer Kendra as New Vice President of Strategic Partnerships New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-Path.
February 20, 2025 Vivli and RDCA-DAP Present: Data Platform Partnerships to Promote Rare Disease Data Sharing Join Julie Wood, Chief Operating Officer at Vivli, for an engaging webinar, Thursday, February 20, where she’ll discuss...
January 21, 2025 Save the Date: CGIC Returns to D.C. this September We are thrilled to invite you to the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC)...
January 17, 2025 FDA Accepts Qualification Plan for Urine Biomarker Panel to Allow Earlier Detection of Response to Drug-Induced Kidney Injury in Clinical Trials The Foundation for the National Institutes of Health (FNIH) and Critical Path Institute® (C-Path)...
January 17, 2025 CP-RND ALS Public-Private Partnership Public Forum A public forum for stakeholders Critical Path Institute's (C-Path) Critical Path for Rare and Neurodegenerative Diseases...
January 15, 2025 C-Path Welcomes Bayer Pharma as Newest Member of CPP C-Path is excited to welcome Bayer Pharma as a the newest member of the organization's Critical Path for Parkinson’s (CPP)...
January 14, 2025 C-Path’s TRxA Announces 2025 Request for Proposals from Academic Investigators C-Path and TRxA today officially launched its 2025 global Request for Proposals for Bridging Research...
January 12, 2025 National Pharmacist Day: Recognizing These Pillars in Healthcare Every year on January 12th, we pause to celebrate National Pharmacist Day — a day dedicated to recognizing the vital role...
